Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
October 19, 2015 16:08 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference
September 03, 2015 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial
August 31, 2015 16:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Reports Second Quarter Financial Results
August 13, 2015 16:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Evofem Announces the Completion of the Largest Phase III Contraceptive Clinical Trial to Date.
June 26, 2014 08:12 ET
|
WomanCare Global
SAN DIEGO, June 26, 2014 (GLOBE NEWSWIRE) -- Evofem announced the completion of the largest Phase III contraceptive clinical trial to date examining the efficacy of its contraceptive vaginal gel...
Conceptus, Inc. Acquisition Investigation
April 29, 2013 13:12 ET
|
WeissLaw LLP
NEW YORK, April 29, 2013 (GLOBE NEWSWIRE) -- WeissLaw LLP, a national class action, shareholder rights law firm with offices in New York and Los Angeles, is examining possible breaches of fiduciary...